Originally from Burlington, VT, Colin Gliech received his bachelor’s and master’s degree in Chemical Biology from Stevens Institute of Technology. After graduation, Colin worked for two years as a technician at Cepter Biopartners, a small biotech startup focused on developing cancer drugs, before joining the Biochemistry Cellular and Molecular Biology program at the Johns Hopkins School of Medicine. He is now a fifth-year PhD candidate in the Holland Lab where he studies the mechanism of a fail-safe mitotic cellular clock that triages problematic cell divisions, as well as a unique sensitivity of certain cancers to inhibition of the mitotic motor protein KIF18A. Outside of science, Colin is and avid amateur singer, violinist, and actor.
